Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 09-2019 | 06-2019 | 03-2019 | 06-2018 | |
| Sales | 10,277,410 | 11,032,150 | 0 | 9,896,226 | 0 |
| Cost of Goods | 3,160,668 | 3,485,008 | N/A | 2,973,524 | N/A |
| Gross Profit | 7,116,743 | 7,547,144 | N/A | 6,922,701 | N/A |
| Operating Expenses | 4,779,730 | 5,030,696 | 0 | 5,385,353 | 0 |
| Operating Income | 2,337,681 | 2,516,456 | N/A | 1,537,873 | N/A |
| Interest Expense | 108,114 | 121,208 | 0 | 120,395 | 0 |
| Other Income | 119,145 | -12,232 | 0 | 174,913 | 0 |
| Pre-tax Income | 2,348,713 | 2,383,016 | 0 | 1,592,392 | 0 |
| Income Tax | 478,789 | 298,016 | N/A | 289,629 | N/A |
| Net Income Continuous | 1,869,924 | 2,085,000 | N/A | 1,302,763 | N/A |
| Minority Interests | 13,238 | 10,008 | N/A | 11,358 | N/A |
| Net Income | $1,856,686 | $2,074,992 | $N/A | $1,291,405 | $N/A |
| EPS Basic Total Ops | 0.74 | 0.78 | N/A | 0.52 | N/A |
| EPS Basic Continuous Ops | 0.75 | 0.83 | N/A | 0.52 | N/A |
| EPS Diluted Total Ops | 0.74 | 0.78 | N/A | 0.52 | N/A |
| EPS Diluted Continuous Ops | 0.75 | 0.83 | N/A | 0.52 | N/A |
| EBITDA(a) | $2,337,681 | $2,516,456 | $N/A | $1,537,873 | $N/A |